drugset / Trial / NCT03583658
Efficacy and Safety Study of New Ambroxol Hardboiled Lozenges in Acute Pharyngitis
RandomizedParallel-groupDouble-blindTreatment
Summary
Primary Objective: To assess the efficacy of the new hard boiled Ambroxol lozenges 20 mg for the relief of sore throat pain in patients with acute pharyngitis. Secondary Objective: To assess the safety of the new hard boiled Ambroxol lozenges 20 mg in patients with acute pharyngitis.
Timeline
- Start
- 2018-06-30
- Primary completion
- 2018-09-02
- Completion
- 2018-09-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ambroxol | Small molecule | 20 mg | Other |